Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: Update based on the clinical evidence in Spain
- Sanchez-Luna, M.
- Burgos-Pol, R.
- Oyagüez, I.
- Figueras-Aloy, J.
- Sánchez-Solís, M.
- Martinón-Torres, F.
- Carbonell-Estrany, X.
Revista:
BMC Infectious Diseases
ISSN: 1471-2334
Ano de publicación: 2017
Volume: 17
Número: 1
Tipo: Artigo
